Literature DB >> 2009907

Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis.

B Saha1, H Nanda-Roy, A Pakrashi, R N Chakrabarti, S Roy.   

Abstract

Studies were carried out to determine changes in lymphoid organs i.e. spleen, lymph node and bone marrow (BM) in progressive experimental visceral leishmaniasis. Mononuclear phagocytes in the BM were increased; spleens showed a hypercellularity coupled with a rise in parasite burden while secondary follicles with no apparent depletion of paracortex were seen in the lymph node. This enhanced proliferation of mononuclear phagocytes in the BM and probably their subsequent recruitment in the spleen could be induced in naive recipients by injecting nylon wool-purified lymph node cells derived from infected mice together with sonicated leishmanial antigen(s). Similar changes could also be induced in the BM of naive recipients by injecting serum of infected mice. In control experiments where both donor and recipients were uninfected such changes were not apparent. A working hypothesis is proposed to delineate the role of lymphoid organs in the pathogenesis of experimental visceral leishmaniasis.

Entities:  

Mesh:

Year:  1991        PMID: 2009907     DOI: 10.1002/eji.1830210307

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

3.  Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages.

Authors:  Jayati Mookerjee Basu; Ananda Mookerjee; Prosenjit Sen; Suniti Bhaumik; Pradip Sen; Subha Banerjee; Ksudiram Naskar; Soumitra K Choudhuri; Bhaskar Saha; Sanghamitra Raha; Syamal Roy
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.

Authors:  Sanjukta Ghosh; Sandip Bhattacharyya; Madhumita Sirkar; Gouri Shankar Sa; Tanya Das; Debashis Majumdar; Syamal Roy; Subrata Majumdar
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Selective impairment of protein kinase C isotypes in murine macrophage by Leishmania donovani.

Authors:  S Bhattacharyya; S Ghosh; P Sen; S Roy; S Majumdar
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

6.  Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani.

Authors:  S E Cotterell; C R Engwerda; P M Kaye
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events.

Authors:  S Bhattacharyya; S Ghosh; P L Jhonson; S K Bhattacharya; S Majumdar
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.

Authors:  June Ghosh; Shantanabha Das; Rajan Guha; Debopam Ghosh; Kshudiram Naskar; Anjan Das; Syamal Roy
Journal:  J Lipid Res       Date:  2012-10-10       Impact factor: 5.922

9.  Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.

Authors:  B Saha; A M D J Tonkal; S Croft; S Roy
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection.

Authors:  June Ghosh; Mainak Bose; Syamal Roy; Suvendra N Bhattacharyya
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.